0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Based on Gene Therapy Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-12C14361
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Drug Based on Gene Therapy Market Research Report 2023
BUY CHAPTERS

Global Drug Based on Gene Therapy Market Research Report 2025

Code: QYRE-Auto-12C14361
Report
July 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug Based on Gene Therapy Market Size

The global market for Drug Based on Gene Therapy was valued at US$ 14450 million in the year 2024 and is projected to reach a revised size of US$ 77450 million by 2031, growing at a CAGR of 27.5% during the forecast period.

Drug Based on Gene Therapy Market

Drug Based on Gene Therapy Market

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient"s cells instead of using drugs or surgery.
The Drug Based on Gene Therapy market is primarily driven by the revolutionary potential of gene therapy to address genetic disorders at their root cause, offering a new paradigm for treating previously incurable conditions. Gene therapy involves introducing genetic material into a patient"s cells to correct or replace faulty genes, aiming to restore normal cellular function. The increasing understanding of the genetic basis of diseases, coupled with advancements in gene delivery methods and genome editing techniques, contributes to market growth. Moreover, the demonstrated benefits of gene therapy in providing targeted and long-lasting treatments, overcoming limitations of traditional pharmacological approaches, and offering hope to patients with rare genetic disorders further propel adoption. However, challenges include optimizing gene delivery efficiency, addressing potential immune responses, and ensuring the long-term safety and durability of gene-based treatments. Navigating regulatory pathways, conducting rigorous clinical trials, and addressing ethical considerations are ongoing concerns. The market"s success relies on continuous research in genetic medicine, collaborations between biotechnology companies and research institutions, and comprehensive education on the benefits and potential challenges of using gene therapy-based drugs while addressing the evolving challenges associated with precision medicine and personalized treatments.
This report aims to provide a comprehensive presentation of the global market for Drug Based on Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Based on Gene Therapy.
The Drug Based on Gene Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Based on Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Based on Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Drug Based on Gene Therapy Market Report

Report Metric Details
Report Name Drug Based on Gene Therapy Market
Accounted market size in year US$ 14450 million
Forecasted market size in 2031 US$ 77450 million
CAGR 27.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Drug Based on Gene Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Drug Based on Gene Therapy Market growing?

Ans: The Drug Based on Gene Therapy Market witnessing a CAGR of 27.5% during the forecast period 2025-2031.

What is the Drug Based on Gene Therapy Market size in 2031?

Ans: The Drug Based on Gene Therapy Market size in 2031 will be US$ 77450 million.

Who are the main players in the Drug Based on Gene Therapy Market report?

Ans: The main players in the Drug Based on Gene Therapy Market are Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute

What are the Application segmentation covered in the Drug Based on Gene Therapy Market report?

Ans: The Applications covered in the Drug Based on Gene Therapy Market report are Neurological Diseases, Cancer, Other

What are the Type segmentation covered in the Drug Based on Gene Therapy Market report?

Ans: The Types covered in the Drug Based on Gene Therapy Market report are Viral Gene Therapy, Non-viral Gene Therapy

Recommended Reports

Gene Therapy Applications

Gene Delivery & Vectors

Gene-Based Therapeutics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Based on Gene Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Viral Gene Therapy
1.2.3 Non-viral Gene Therapy
1.3 Market by Application
1.3.1 Global Drug Based on Gene Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Based on Gene Therapy Market Perspective (2020-2031)
2.2 Global Drug Based on Gene Therapy Growth Trends by Region
2.2.1 Global Drug Based on Gene Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Based on Gene Therapy Historic Market Size by Region (2020-2025)
2.2.3 Drug Based on Gene Therapy Forecasted Market Size by Region (2026-2031)
2.3 Drug Based on Gene Therapy Market Dynamics
2.3.1 Drug Based on Gene Therapy Industry Trends
2.3.2 Drug Based on Gene Therapy Market Drivers
2.3.3 Drug Based on Gene Therapy Market Challenges
2.3.4 Drug Based on Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Based on Gene Therapy Players by Revenue
3.1.1 Global Top Drug Based on Gene Therapy Players by Revenue (2020-2025)
3.1.2 Global Drug Based on Gene Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Drug Based on Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Based on Gene Therapy Revenue
3.4 Global Drug Based on Gene Therapy Market Concentration Ratio
3.4.1 Global Drug Based on Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Based on Gene Therapy Revenue in 2024
3.5 Global Key Players of Drug Based on Gene Therapy Head office and Area Served
3.6 Global Key Players of Drug Based on Gene Therapy, Product and Application
3.7 Global Key Players of Drug Based on Gene Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Based on Gene Therapy Breakdown Data by Type
4.1 Global Drug Based on Gene Therapy Historic Market Size by Type (2020-2025)
4.2 Global Drug Based on Gene Therapy Forecasted Market Size by Type (2026-2031)
5 Drug Based on Gene Therapy Breakdown Data by Application
5.1 Global Drug Based on Gene Therapy Historic Market Size by Application (2020-2025)
5.2 Global Drug Based on Gene Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Based on Gene Therapy Market Size (2020-2031)
6.2 North America Drug Based on Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Based on Gene Therapy Market Size by Country (2020-2025)
6.4 North America Drug Based on Gene Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Based on Gene Therapy Market Size (2020-2031)
7.2 Europe Drug Based on Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Based on Gene Therapy Market Size by Country (2020-2025)
7.4 Europe Drug Based on Gene Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Based on Gene Therapy Market Size (2020-2031)
8.2 Asia-Pacific Drug Based on Gene Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Based on Gene Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Based on Gene Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Based on Gene Therapy Market Size (2020-2031)
9.2 Latin America Drug Based on Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Based on Gene Therapy Market Size by Country (2020-2025)
9.4 Latin America Drug Based on Gene Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Based on Gene Therapy Market Size (2020-2031)
10.2 Middle East & Africa Drug Based on Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Drug Based on Gene Therapy Introduction
11.1.4 Biogen Revenue in Drug Based on Gene Therapy Business (2020-2025)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Drug Based on Gene Therapy Introduction
11.2.4 Novartis Revenue in Drug Based on Gene Therapy Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Drug Based on Gene Therapy Introduction
11.3.4 Gilead Sciences Revenue in Drug Based on Gene Therapy Business (2020-2025)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Drug Based on Gene Therapy Introduction
11.4.4 Sarepta Therapeutics Revenue in Drug Based on Gene Therapy Business (2020-2025)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Drug Based on Gene Therapy Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Drug Based on Gene Therapy Business (2020-2025)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Drug Based on Gene Therapy Introduction
11.6.4 Amgen Revenue in Drug Based on Gene Therapy Business (2020-2025)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Drug Based on Gene Therapy Introduction
11.7.4 Spark Therapeutics Revenue in Drug Based on Gene Therapy Business (2020-2025)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Drug Based on Gene Therapy Introduction
11.8.4 Akcea Therapeutics Revenue in Drug Based on Gene Therapy Business (2020-2025)
11.8.5 Akcea Therapeutics Recent Development
11.9 bluebird bio
11.9.1 bluebird bio Company Details
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Drug Based on Gene Therapy Introduction
11.9.4 bluebird bio Revenue in Drug Based on Gene Therapy Business (2020-2025)
11.9.5 bluebird bio Recent Development
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Details
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Drug Based on Gene Therapy Introduction
11.10.4 Sunway Biotech Revenue in Drug Based on Gene Therapy Business (2020-2025)
11.10.5 Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Details
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Drug Based on Gene Therapy Introduction
11.11.4 SIBIONO Revenue in Drug Based on Gene Therapy Business (2020-2025)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Details
11.12.2 AnGes Business Overview
11.12.3 AnGes Drug Based on Gene Therapy Introduction
11.12.4 AnGes Revenue in Drug Based on Gene Therapy Business (2020-2025)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Details
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Drug Based on Gene Therapy Introduction
11.13.4 Orchard Therapeutics Revenue in Drug Based on Gene Therapy Business (2020-2025)
11.13.5 Orchard Therapeutics Recent Development
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Details
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Drug Based on Gene Therapy Introduction
11.14.4 Human Stem Cells Institute Revenue in Drug Based on Gene Therapy Business (2020-2025)
11.14.5 Human Stem Cells Institute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Drug Based on Gene Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Viral Gene Therapy
 Table 3. Key Players of Non-viral Gene Therapy
 Table 4. Global Drug Based on Gene Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Drug Based on Gene Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Drug Based on Gene Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Drug Based on Gene Therapy Market Share by Region (2020-2025)
 Table 8. Global Drug Based on Gene Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Drug Based on Gene Therapy Market Share by Region (2026-2031)
 Table 10. Drug Based on Gene Therapy Market Trends
 Table 11. Drug Based on Gene Therapy Market Drivers
 Table 12. Drug Based on Gene Therapy Market Challenges
 Table 13. Drug Based on Gene Therapy Market Restraints
 Table 14. Global Drug Based on Gene Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Drug Based on Gene Therapy Market Share by Players (2020-2025)
 Table 16. Global Top Drug Based on Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Based on Gene Therapy as of 2024)
 Table 17. Ranking of Global Top Drug Based on Gene Therapy Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Drug Based on Gene Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Drug Based on Gene Therapy, Headquarters and Area Served
 Table 20. Global Key Players of Drug Based on Gene Therapy, Product and Application
 Table 21. Global Key Players of Drug Based on Gene Therapy, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Drug Based on Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Drug Based on Gene Therapy Revenue Market Share by Type (2020-2025)
 Table 25. Global Drug Based on Gene Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Drug Based on Gene Therapy Revenue Market Share by Type (2026-2031)
 Table 27. Global Drug Based on Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Drug Based on Gene Therapy Revenue Market Share by Application (2020-2025)
 Table 29. Global Drug Based on Gene Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Drug Based on Gene Therapy Revenue Market Share by Application (2026-2031)
 Table 31. North America Drug Based on Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Drug Based on Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Drug Based on Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Drug Based on Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Drug Based on Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Drug Based on Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Drug Based on Gene Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Drug Based on Gene Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Drug Based on Gene Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Drug Based on Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Drug Based on Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Drug Based on Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Drug Based on Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Drug Based on Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Biogen Company Details
 Table 47. Biogen Business Overview
 Table 48. Biogen Drug Based on Gene Therapy Product
 Table 49. Biogen Revenue in Drug Based on Gene Therapy Business (2020-2025) & (US$ Million)
 Table 50. Biogen Recent Development
 Table 51. Novartis Company Details
 Table 52. Novartis Business Overview
 Table 53. Novartis Drug Based on Gene Therapy Product
 Table 54. Novartis Revenue in Drug Based on Gene Therapy Business (2020-2025) & (US$ Million)
 Table 55. Novartis Recent Development
 Table 56. Gilead Sciences Company Details
 Table 57. Gilead Sciences Business Overview
 Table 58. Gilead Sciences Drug Based on Gene Therapy Product
 Table 59. Gilead Sciences Revenue in Drug Based on Gene Therapy Business (2020-2025) & (US$ Million)
 Table 60. Gilead Sciences Recent Development
 Table 61. Sarepta Therapeutics Company Details
 Table 62. Sarepta Therapeutics Business Overview
 Table 63. Sarepta Therapeutics Drug Based on Gene Therapy Product
 Table 64. Sarepta Therapeutics Revenue in Drug Based on Gene Therapy Business (2020-2025) & (US$ Million)
 Table 65. Sarepta Therapeutics Recent Development
 Table 66. Alnylam Pharmaceuticals Company Details
 Table 67. Alnylam Pharmaceuticals Business Overview
 Table 68. Alnylam Pharmaceuticals Drug Based on Gene Therapy Product
 Table 69. Alnylam Pharmaceuticals Revenue in Drug Based on Gene Therapy Business (2020-2025) & (US$ Million)
 Table 70. Alnylam Pharmaceuticals Recent Development
 Table 71. Amgen Company Details
 Table 72. Amgen Business Overview
 Table 73. Amgen Drug Based on Gene Therapy Product
 Table 74. Amgen Revenue in Drug Based on Gene Therapy Business (2020-2025) & (US$ Million)
 Table 75. Amgen Recent Development
 Table 76. Spark Therapeutics Company Details
 Table 77. Spark Therapeutics Business Overview
 Table 78. Spark Therapeutics Drug Based on Gene Therapy Product
 Table 79. Spark Therapeutics Revenue in Drug Based on Gene Therapy Business (2020-2025) & (US$ Million)
 Table 80. Spark Therapeutics Recent Development
 Table 81. Akcea Therapeutics Company Details
 Table 82. Akcea Therapeutics Business Overview
 Table 83. Akcea Therapeutics Drug Based on Gene Therapy Product
 Table 84. Akcea Therapeutics Revenue in Drug Based on Gene Therapy Business (2020-2025) & (US$ Million)
 Table 85. Akcea Therapeutics Recent Development
 Table 86. bluebird bio Company Details
 Table 87. bluebird bio Business Overview
 Table 88. bluebird bio Drug Based on Gene Therapy Product
 Table 89. bluebird bio Revenue in Drug Based on Gene Therapy Business (2020-2025) & (US$ Million)
 Table 90. bluebird bio Recent Development
 Table 91. Sunway Biotech Company Details
 Table 92. Sunway Biotech Business Overview
 Table 93. Sunway Biotech Drug Based on Gene Therapy Product
 Table 94. Sunway Biotech Revenue in Drug Based on Gene Therapy Business (2020-2025) & (US$ Million)
 Table 95. Sunway Biotech Recent Development
 Table 96. SIBIONO Company Details
 Table 97. SIBIONO Business Overview
 Table 98. SIBIONO Drug Based on Gene Therapy Product
 Table 99. SIBIONO Revenue in Drug Based on Gene Therapy Business (2020-2025) & (US$ Million)
 Table 100. SIBIONO Recent Development
 Table 101. AnGes Company Details
 Table 102. AnGes Business Overview
 Table 103. AnGes Drug Based on Gene Therapy Product
 Table 104. AnGes Revenue in Drug Based on Gene Therapy Business (2020-2025) & (US$ Million)
 Table 105. AnGes Recent Development
 Table 106. Orchard Therapeutics Company Details
 Table 107. Orchard Therapeutics Business Overview
 Table 108. Orchard Therapeutics Drug Based on Gene Therapy Product
 Table 109. Orchard Therapeutics Revenue in Drug Based on Gene Therapy Business (2020-2025) & (US$ Million)
 Table 110. Orchard Therapeutics Recent Development
 Table 111. Human Stem Cells Institute Company Details
 Table 112. Human Stem Cells Institute Business Overview
 Table 113. Human Stem Cells Institute Drug Based on Gene Therapy Product
 Table 114. Human Stem Cells Institute Revenue in Drug Based on Gene Therapy Business (2020-2025) & (US$ Million)
 Table 115. Human Stem Cells Institute Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. Drug Based on Gene Therapy Picture
 Figure 2. Global Drug Based on Gene Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drug Based on Gene Therapy Market Share by Type: 2024 VS 2031
 Figure 4. Viral Gene Therapy Features
 Figure 5. Non-viral Gene Therapy Features
 Figure 6. Global Drug Based on Gene Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Drug Based on Gene Therapy Market Share by Application: 2024 VS 2031
 Figure 8. Neurological Diseases Case Studies
 Figure 9. Cancer Case Studies
 Figure 10. Other Case Studies
 Figure 11. Drug Based on Gene Therapy Report Years Considered
 Figure 12. Global Drug Based on Gene Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Drug Based on Gene Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Drug Based on Gene Therapy Market Share by Region: 2024 VS 2031
 Figure 15. Global Drug Based on Gene Therapy Market Share by Players in 2024
 Figure 16. Global Top Drug Based on Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Based on Gene Therapy as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Drug Based on Gene Therapy Revenue in 2024
 Figure 18. North America Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Drug Based on Gene Therapy Market Share by Country (2020-2031)
 Figure 20. United States Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Drug Based on Gene Therapy Market Share by Country (2020-2031)
 Figure 24. Germany Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Drug Based on Gene Therapy Market Share by Region (2020-2031)
 Figure 32. China Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Drug Based on Gene Therapy Market Share by Country (2020-2031)
 Figure 40. Mexico Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Drug Based on Gene Therapy Market Share by Country (2020-2031)
 Figure 44. Turkey Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Drug Based on Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Biogen Revenue Growth Rate in Drug Based on Gene Therapy Business (2020-2025)
 Figure 48. Novartis Revenue Growth Rate in Drug Based on Gene Therapy Business (2020-2025)
 Figure 49. Gilead Sciences Revenue Growth Rate in Drug Based on Gene Therapy Business (2020-2025)
 Figure 50. Sarepta Therapeutics Revenue Growth Rate in Drug Based on Gene Therapy Business (2020-2025)
 Figure 51. Alnylam Pharmaceuticals Revenue Growth Rate in Drug Based on Gene Therapy Business (2020-2025)
 Figure 52. Amgen Revenue Growth Rate in Drug Based on Gene Therapy Business (2020-2025)
 Figure 53. Spark Therapeutics Revenue Growth Rate in Drug Based on Gene Therapy Business (2020-2025)
 Figure 54. Akcea Therapeutics Revenue Growth Rate in Drug Based on Gene Therapy Business (2020-2025)
 Figure 55. bluebird bio Revenue Growth Rate in Drug Based on Gene Therapy Business (2020-2025)
 Figure 56. Sunway Biotech Revenue Growth Rate in Drug Based on Gene Therapy Business (2020-2025)
 Figure 57. SIBIONO Revenue Growth Rate in Drug Based on Gene Therapy Business (2020-2025)
 Figure 58. AnGes Revenue Growth Rate in Drug Based on Gene Therapy Business (2020-2025)
 Figure 59. Orchard Therapeutics Revenue Growth Rate in Drug Based on Gene Therapy Business (2020-2025)
 Figure 60. Human Stem Cells Institute Revenue Growth Rate in Drug Based on Gene Therapy Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS